Metronomic PLD in Patients With Primary Endocrine Resistant ABC
NCT03071926
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Advanced Breast Cancer
Interventions
DRUG:
Pegylated Liposomal Doxorubicin
Sponsor
Fudan University